Lipid Processing in the Brain: A Key Regulator of Systemic Metabolism
Metabolic disorders, particularly aberrations in lipid homeostasis, such as obesity, type 2 diabetes mellitus, and hypertriglyceridemia often manifest together as the metabolic syndrome (MetS). Despite major advances in our understanding of the pathogenesis of these disorders, the prevalence of the...
Saved in:
Published in: | Frontiers in endocrinology (Lausanne) Vol. 8; p. 60 |
---|---|
Main Authors: | , , |
Format: | Journal Article |
Language: | English |
Published: |
Switzerland
Frontiers Media S.A
04-04-2017
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Metabolic disorders, particularly aberrations in lipid homeostasis, such as obesity, type 2 diabetes mellitus, and hypertriglyceridemia often manifest together as the metabolic syndrome (MetS). Despite major advances in our understanding of the pathogenesis of these disorders, the prevalence of the MetS continues to rise. It is becoming increasingly apparent that intermediary metabolism within the central nervous system is a major contributor to the regulation of systemic metabolism. In particular, lipid metabolism within the brain is tightly regulated to maintain neuronal structure and function and may signal nutrient status to modulate metabolism in key peripheral tissues such as the liver. There is now a growing body of evidence to suggest that fatty acid (FA) sensing in hypothalamic neurons
accumulation of FAs or FA metabolites may signal nutritional sufficiency and may decrease hepatic glucose production, lipogenesis, and VLDL-TG secretion. In addition, recent studies have highlighted the existence of liver-related neurons that have the potential to direct such signals through parasympathetic and sympathetic nervous system activity. However, to date whether these liver-related neurons are FA sensitive remain to be determined. The findings discussed in this review underscore the importance of the autonomic nervous system in the regulation of systemic metabolism and highlight the need for further research to determine the key features of FA neurons, which may serve as novel therapeutic targets for the treatment of metabolic disorders. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 Edited by: Hubert Vaudry, University of Rouen, France Specialty section: This article was submitted to Neuroendocrine Science, a section of the journal Frontiers in Endocrinology Reviewed by: Alexandre Benani, Centre national de la recherche scientifique (CNRS), France; Miguel Lopez, Universidade de Santiago de Compostela, Spain; Christelle Le Foll, University of Zurich, Switzerland |
ISSN: | 1664-2392 1664-2392 |
DOI: | 10.3389/fendo.2017.00060 |